Helius Medical Technologies, Inc

(NASDAQ:HSDT)

Latest On Helius Medical Technologies, Inc (HSDT):

Date/Time Type Description Signal Details
2023-05-11 20:40 ESTNewsHelius Medical Technologies GAAP EPS of -$0.09 beats by $0.02, revenue of $0.11M misses by $0.17MN/A
2023-05-11 20:40 ESTNewsHelius Medical Technologies, Inc. (HSDT) Q1 2023 Earnings Call TranscriptN/A
2023-03-11 00:13 ESTNewsHelius Medical Technologies, Inc. (HSDT) Q4 2022 Earnings Call TranscriptN/A
2023-03-09 17:42 ESTNewsHelius stock rises on expanded approval of Neuromodulation Stimulator in CanadaN/A
2023-03-09 17:41 ESTNewsHelius Medical Technologies GAAP EPS of -$0.17 misses by $0.04, revenue of $0.28M misses by $0.01MN/A
2023-01-23 15:54 ESTNewsHelius Medical projects 50% growth for annual revenuesN/A
2022-11-15 03:14 ESTNewsHelius Medical Technologies, Inc. (HSDT) Q3 2022 Earnings Call TranscriptN/A
2022-11-14 09:55 ESTNewsHelius Medical Technologies GAAP EPS of -$0.12, revenue of $0.19MN/A
2022-08-24 05:09 ESTNewsHelius Medical Technologies: A Net-Net Meme Stock In The MakingN/A
2022-08-24 05:09 ESTNewsHelius Medical adds 32% as Roth launches coverage with BuyN/A
2022-08-16 08:51 ESTNewsHelius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-15 16:29 ESTNewsHelius Medical Technologies GAAP EPS of -$0.97 beats by $0.15, revenue of $0.12M misses by $0.24MN/A
2022-08-05 19:17 ESTNewsHelius Medical Technologies stock slides 51% after pricing $18M securities offeringN/A
2022-06-01 15:56 ESTNewsHelius stock soars 38% on launch of patient program for neuromodulation stimulator therapyN/A
2022-05-12 18:27 ESTNewsHelius Medical Technologies GAAP EPS of $1.15 beats by $2.28, revenue of $0.19M beats by $0.03MN/A
2022-05-12 18:27 ESTNewsHelius Medical Technologies' (HSDT) CEO Dane Andreeff on Q1 2022 Results - Earnings Call TranscriptN/A
2022-03-15 04:29 ESTNewsHelius Medical Technologies GAAP EPS of -$1.31 misses by $0.15, revenue of $0.26M beats by $0.16MN/A
2022-03-15 04:28 ESTNewsHelius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q4 2021 Results - Earnings Call TranscriptN/A
2021-12-14 15:44 ESTNewsHelius Medical rallies on issuance of U.S. Patent for wireless PoNSN/A
2021-11-11 07:11 ESTNewsHelius Medical Technologies EPS misses by $0.28, misses on revenueN/A
2021-11-11 07:11 ESTNewsHelius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff On Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 09:31 ESTNewsHelius Medical Technologies launches stock offeringN/A
2021-11-04 10:24 ESTNewsHelius Medical's PoNS device gets market authorization in AustraliaN/A
2021-10-13 02:15 ESTNewsWarning: HSDT is at high risk of performing badlyN/A
2021-10-06 09:28 ESTNewsHSDT is at high risk of performing badlyN/A
2021-09-27 19:02 ESTNewsWarning: HSDT has been downgraded to Very BearishN/A
2021-09-23 04:39 ESTNewsWarning: HSDT has been downgraded to Very Bearish.N/A
2021-08-17 14:48 ESTNewsHelius Medical climbs on FDA Breakthrough Designation for device targeting stroke patientsN/A
2021-08-13 14:44 ESTNewsHelius Medical Technologies' (HSDT) CEO Dane Andreeff on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-12 18:24 ESTNewsHelius Medical Technologies EPS misses by $0.97, misses on revenueN/A
2021-07-21 11:28 ESTNewsHelius Medical Technologies announces new appointments to executive leadership teamN/A
2021-07-21 11:28 ESTNewsHelius Medical makes CEO, CFO appointmentsN/A
2021-07-21 11:13 ESTNewsHelius Medical names Antonella Favit-Van Pelt as chief medical officerN/A
2021-03-27 04:56 ESTNewsHelius Medical surges on FDA authorization for neuromodulation stimulator (updated)N/A
2021-03-12 07:51 ESTFinancialsCompany financials have been released.Neutral
2021-03-11 08:17 ESTNewsHelius Medical Technologies EPS misses by $1.69, beats on revenueN/A
2021-03-11 08:17 ESTNewsHelius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q4 2020 Results - Earnings Call TranscriptN/A
2021-01-29 01:30 ESTNewsHelius Medical drops 16% after $9.6M capital raiseN/A
2021-01-19 13:29 ESTNewsHelius Medical regains Nasdaq listing complianceN/A
2021-01-05 11:58 ESTStock SplitA stock split has occured on Jan 4, 2021 with a split factor of 1:35.Neutral
2020-12-31 16:57 ESTNewsHelius Medical Technologies announces reverse stock splitN/A
2020-11-26 20:19 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 20:08 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 01:05 ESTNewsHelius Medical Technologies EPS beats by $0.01, beats on revenueN/A
2020-11-13 01:04 ESTNewsHelius Medical Technologies' (HSDT) Management on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-07 16:05 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 11:56 ESTFinancialsCompany financials have been released.Neutral
2020-10-26 18:50 ESTNewsHelius Medical announces $3.4M private placementN/A
2020-10-26 16:38 ESTInsider TradeDANE ANDREEFF has indirectly acquired of 37,363 shares.Buy
2020-10-26 16:38 ESTInsider TradeDANE ANDREEFF has indirectly acquired of 371,883 shares.Buy

About Helius Medical Technologies, Inc (HSDT):

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.

HSDT Quotes by TradingView

See Advanced Chart

General

  • Name Helius Medical Technologies, Inc
  • Symbol HSDT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Devices
  • Full Time Employees 19
  • Last Split Factor1:35
  • Last Split Date2021-01-04
  • Fiscal Year EndDecember
  • IPO Date2014-06-27
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Gic SubIndustryHealth Care Equipment
  • Web URLhttp://heliusmedical.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 23.64
  • Price/Book (Most Recent Quarter) 10.24
  • Enterprise Value Revenue 45.21
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Operating Margin -2689%
  • Return on Assets -111%
  • Return on Equity -282%
  • Revenue 622000
  • Earnings Per Share -$0.34
  • Revenue Per Share $0.6
  • Gross Profit 650000
  • Quarterly Earnings Growth -12.7%
View More

Highlights

  • Market Capitalization 21.53 million
  • EBITDA -22703000
  • PE Ratio -0.31
  • Analyst Target Price $2.12
  • Book Value Per Share $2.47
View More

Share Statistics

  • Shares Outstanding 1.5 million
  • Shares Float 1.48 million
  • % Held by Insiders 1838%
  • % Held by Institutions 17.53%
  • Shares Short 31266
  • Shares Short Prior Month 23772
  • Short Ratio 5.33
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 0.77
  • 52 Week High $23.77
  • 52 Week Low $8.72
  • 50 Day Moving Average 14.06
  • 200 Day Moving Average 14.46
View More

Dividends

  • Dividend Date 2021-01-04
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Helius Medical Technologies, Inc (HSDT) Dividend Calendar:

HSDT's last dividend payment was made to shareholders on January 4, 2021.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Helius Medical Technologies, Inc (HSDT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$190000-$1.77-$0.08-2112.5%
2020-09-302020-11-12$N/A-$2.80-$3.1511.11%
2020-06-302020-08-12$N/A-$2.80-$4.2033.33%
2020-03-312020-05-07$207000-$5.25-$5.606.25%
2019-12-312020-03-12$152000-$6.65-$7.359.52%
2019-09-302019-11-12$150000-$7.70-$7.700%
2019-06-302019-08-08$518000-$0.35-$7.8895.56%
2019-03-312019-05-09$677000$1.75-$8.93119.61%
2018-12-312019-03-14$478000-$7.35-$7.532.33%
2018-09-302018-11-08$N/A-$6.65-$8.0517.39%
2018-06-302018-08-09$N/A-$27.30-$8.05-239.13%
2018-03-312018-05-08$N/A-$2.10
2017-12-312018-03-12$N/A-$0.18
2017-09-302017-11-09$N/A-$0.67
2017-06-302017-08-11$N/A-$0.30-$0.05-500%
2017-03-312017-04-03$N/A-$0.30
2016-12-312016-12-31$N/A-$0.35-$0.03-1066.67%
2016-09-302016-11-14$N/A-$7.00-$0.03-23233.33%
2016-06-302016-08-15$N/A-$7.00-$0.03-23233.33%
2016-03-312016-06-28$N/A-$5.25-$8.7540%
2015-12-312016-02-16$N/A-$0.20-$0.200%
2015-09-302015-11-16$N/A$0.10-$0.05300%
2015-06-302015-08-11$N/A-$0.25-$0.4037.5%
2015-03-312015-06-29$N/A$0.05-$0.10150%
2014-12-312015-03-15$N/A-$0.06-$0.05-20%
2014-09-302014-11-15$N/A-$0.04-$0.03-33.33%
2014-06-302014-08-29$N/A-$0.04

Helius Medical Technologies, Inc (HSDT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Helius Medical Technologies, Inc (HSDT) Chart:

Helius Medical Technologies, Inc (HSDT) News:

Below you will find a list of latest news for Helius Medical Technologies, Inc (HSDT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Helius Medical Technologies, Inc (HSDT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest HSDT Trades:

Date Shares Price
Jun 13, 2022 2:53 PM EST200$1.61
Jun 13, 2022 5:55 PM EST500$1.56

Helius Medical Technologies, Inc (HSDT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-028-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000119312520186797/0001193125-20-186797-index.htm
2020-09-23UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1610853/000000000020008949/0000000000-20-008949-index.htm
2020-03-30DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000090571820000330/0000905718-20-000330-index.htm
2020-03-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1610853/000091957420002634/0000919574-20-002634-index.htm
2020-03-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1610853/000119312520076644/0001193125-20-076644-index.htm
2020-03-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1610853/000119312520077331/0001193125-20-077331-index.htm
2020-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000119312520108654/0001193125-20-108654-index.htm
2020-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000119312520114242/0001193125-20-114242-index.htm
2020-04-28PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1610853/000119312520121683/0001193125-20-121683-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000119312520127759/0001193125-20-127759-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000119312520136362/0001193125-20-136362-index.htm
2020-05-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1610853/000119312520139219/0001193125-20-139219-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000119312520139927/0001193125-20-139927-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000119312520167183/0001193125-20-167183-index.htm
2020-07-028-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000119312520186797/0001193125-20-186797-index.htm
2020-07-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000119312520192265/0001193125-20-192265-index.htm
2020-09-15S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1610853/000119312520246308/0001193125-20-246308-index.htm
2020-09-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1610853/000119312520252131/0001193125-20-252131-index.htm
2020-09-28424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1610853/000119312520255579/0001193125-20-255579-index.htm
2020-11-05SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1610853/000119312520287016/0001193125-20-287016-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120009885/0001209191-20-009885-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120009886/0001209191-20-009886-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120014443/0001209191-20-014443-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120014445/0001209191-20-014445-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120019389/0001209191-20-019389-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120019394/0001209191-20-019394-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120020579/0001209191-20-020579-index.htm
2020-04-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120023567/0001209191-20-023567-index.htm
2020-04-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120023569/0001209191-20-023569-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120024746/0001209191-20-024746-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120024748/0001209191-20-024748-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120025152/0001209191-20-025152-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120026455/0001209191-20-026455-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120026456/0001209191-20-026456-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120029577/0001209191-20-029577-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120029581/0001209191-20-029581-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120030046/0001209191-20-030046-index.htm
2020-05-194/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120030349/0001209191-20-030349-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120030507/0001209191-20-030507-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120033153/0001209191-20-033153-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120036341/0001209191-20-036341-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120036349/0001209191-20-036349-index.htm
2020-06-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120036361/0001209191-20-036361-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120036454/0001209191-20-036454-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120036457/0001209191-20-036457-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120036949/0001209191-20-036949-index.htm
2020-06-164/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120036988/0001209191-20-036988-index.htm
2020-06-163/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120036993/0001209191-20-036993-index.htm
2020-06-164/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120037012/0001209191-20-037012-index.htm
2020-06-164/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120037015/0001209191-20-037015-index.htm
2020-06-164/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120037028/0001209191-20-037028-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120040096/0001209191-20-040096-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120042598/0001209191-20-042598-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120044399/0001209191-20-044399-index.htm
2020-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120054124/0001209191-20-054124-index.htm
2020-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120054127/0001209191-20-054127-index.htm
2020-10-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120055810/0001209191-20-055810-index.htm
2020-10-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1610853/000120919120055814/0001209191-20-055814-index.htm
2020-03-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1610853/000153561020000081/0001535610-20-000081-index.htm
2020-02-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020005320/0001564590-20-005320-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020007966/0001564590-20-007966-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020010456/0001564590-20-010456-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1610853/000156459020010496/0001564590-20-010496-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020011626/0001564590-20-011626-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020012315/0001564590-20-012315-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020013609/0001564590-20-013609-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1610853/000156459020024198/0001564590-20-024198-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020037233/0001564590-20-037233-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020039684/0001564590-20-039684-index.htm
2020-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1610853/000156459020039685/0001564590-20-039685-index.htm
2020-08-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020041093/0001564590-20-041093-index.htm
2020-09-0810-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1610853/000156459020042819/0001564590-20-042819-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020043012/0001564590-20-043012-index.htm
2020-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020046019/0001564590-20-046019-index.htm
2020-10-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020046799/0001564590-20-046799-index.htm
2020-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020047107/0001564590-20-047107-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020047638/0001564590-20-047638-index.htm
2020-10-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1610853/000156459020047881/0001564590-20-047881-index.htm
2020-09-25EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1610853/999999999520002583/9999999995-20-002583-index.htm

Helius Medical Technologies, Inc (HSDT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Helius Medical Technologies, Inc (HSDT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1838%
Institutional Ownership: 1753%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-30Joyce N LaViscountCFO and COOBuy6,429.000.432,764.47100,347.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120040096/0001209191-20-040096-index.htm
2020-07-15Joyce N LaViscountCFO and COOBuy5,312.000.522,745.24105,659.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120042598/0001209191-20-042598-index.htm
2020-07-31Joyce N LaViscountCFO and COOBuy4,946.000.562,745.03110,605.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120044399/0001209191-20-044399-index.htm
2020-10-21DANE ANDREEFFInterim President and CEOBuy638,182.000.46294,776.271,420,525.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120055810/0001209191-20-055810-index.htm
2020-10-21Joyce N LaViscountCFO and COOBuy38,138.000.4617,615.94148,743.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120055814/0001209191-20-055814-index.htm
2020-05-13DANE ANDREEFFDirectorBuy17,038.000.579,711.66149,042.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120029581/0001209191-20-029581-index.htm
2020-05-15DANE ANDREEFFDirectorBuy11,359.000.566,361.04166,080.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120030507/0001209191-20-030507-index.htm
2020-05-13DANE ANDREEFFDirectorBuy4,578.000.572,609.4617,004.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120029581/0001209191-20-029581-index.htm
2020-05-15DANE ANDREEFFDirectorBuy3,052.000.561,709.1221,582.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120030507/0001209191-20-030507-index.htm
2020-10-21DANE ANDREEFFInterim President and CEOBuy134,873.000.4662,297.84300,953.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120055810/0001209191-20-055810-index.htm
2020-05-13DANE ANDREEFFDirectorBuy47,430.000.5727,035.10396,529.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120029581/0001209191-20-029581-index.htm
2020-02-14Philippe DeschampsPresident and CEOBuy4,704.000.853,998.4041,711.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120009885/0001209191-20-009885-index.htm
2020-02-14Joyce N LaViscountCFO and COOBuy3,229.000.852,744.6543,516.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120009886/0001209191-20-009886-index.htm
2020-05-15DANE ANDREEFFDirectorBuy31,620.000.5617,707.20443,959.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120030507/0001209191-20-030507-index.htm
2020-02-28Philippe DeschampsPresident and CEOBuy4,394.000.913,998.5446,105.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120014445/0001209191-20-014445-index.htm
2020-02-28Joyce N LaViscountCFO and COOBuy3,016.000.912,744.5646,532.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120014443/0001209191-20-014443-index.htm
2020-03-13Joyce N LaViscountCFO and COOBuy5,841.000.472,745.2752,373.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120019394/0001209191-20-019394-index.htm
2020-03-13Philippe DeschampsPresident and CEOBuy8,507.000.473,998.2954,612.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120019389/0001209191-20-019389-index.htm
2020-10-21DANE ANDREEFFInterim President and CEOBuy37,363.000.4617,257.9758,945.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120055810/0001209191-20-055810-index.htm
2020-03-31Joyce N LaViscountCFO and COOBuy8,319.000.332,745.2760,692.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120023569/0001209191-20-023569-index.htm
2020-03-31Philippe DeschampsPresident and CEOBuy12,117.000.333,998.6166,729.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120023567/0001209191-20-023567-index.htm
2020-05-13DANE ANDREEFFDirectorBuy80,954.000.5746,143.78701,389.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120029581/0001209191-20-029581-index.htm
2020-04-15Joyce N LaViscountCFO and COOBuy10,167.000.272,745.0970,859.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120024748/0001209191-20-024748-index.htm
2020-04-30Joyce N LaViscountCFO and COOBuy6,399.000.432,751.5777,258.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120026456/0001209191-20-026456-index.htm
2020-05-15DANE ANDREEFFDirectorBuy53,969.000.5630,222.64782,343.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120030507/0001209191-20-030507-index.htm
2020-04-15Philippe DeschampsPresident and CEOBuy14,809.000.273,998.4381,538.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120024746/0001209191-20-024746-index.htm
2020-10-21DANE ANDREEFFInterim President and CEOBuy371,883.000.46171,772.76815,842.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120055810/0001209191-20-055810-index.htm
2020-05-15Joyce N LaViscountCFO and COOBuy5,501.000.502,750.5082,759.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120030046/0001209191-20-030046-index.htm
2020-05-29Joyce N LaViscountCFO and COOBuy5,557.000.492,722.9388,316.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120033153/0001209191-20-033153-index.htm
2020-04-30Philippe DeschampsPresident and CEOBuy9,320.000.434,007.6090,858.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120026455/0001209191-20-026455-index.htm
2020-06-15Joyce N LaViscountCFO and COOBuy5,602.000.492,744.9893,918.00https://www.sec.gov/Archives/edgar/data/1610853/000120919120036949/0001209191-20-036949-index.htm